More information about location
Health IT and clinical research company
Job no longer available
Health IT and clinical research company
1001+ employees
Job no longer available
More information about location
1001+ employees
To be a catalyst for innovation in healthcare, to drive healthcare forward every day, and make the extraordinary possible for patients.
IQVIA is a world leader in analytics and clinical research in the life sciences sector. Formed from a merger between IMS Health and Quintiles, it has over 40 years of experience in the sector and has grown to become one of the world’s largest contract research organisations, with a network spanning more than 100 countries.
Since its founding, IQVIA has outperformed the market, with is main concerns being in the expansion of biosimilar firms such as Humira which are able to provide generic drugs from existing medications, without needing further data analysis. However IQVIA’s involvement in new areas of research are likely to more than offset this trend.
With global medicine spend on track to reach £1.3 trillion by 2025, IQVIA is focusing its efforts on oncology and immunology, the most profitable sectors in pharmaceutical development. It is also building out its technological infrastructure, with a particular focus on artificial intelligence. While it is frank about the limitations of this technology within the sector, it is able to greatly augment the data-handling capabilities of health science teams. Development in this sector is key to IQVIA’s growth plans for 2025 and beyond, which is on track with 2023-24 seeing a massive increase in company share value.
Kirsty
Company Specialist
Research Triangle, Durham, NC
Founders
Ari Bousbib
(CEO, not founder)Was previously CEO of IMS Health, one of the parent companies of IQVIA. Before that held senior leadership positions at United Technologies Company, including COO of Otis and eventually becoming President of the UTC group with responsibility for 150,000 employees.
Share this job
View 12 more jobs at IQVIA